Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 14, 2014; 20(34): 12132-12143
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12132
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12132
Treatment strategy | Compounds | Genotype 1 | Genotype 2 | Genotype 3 | Genotype 4 | Genotype 5 | Genotype 6 |
Interferon Based | Sofosbuvir | × | × | × | × | × | × |
Simeprevir | × | × | |||||
Daclatasavir | × | × | × | × | × | ||
Interferon free | Sofosbuvir + ribavirin | × | × | ||||
Sofosbuvir + simeprevir | × | × | |||||
Sofosbuvir + daclatasavir | × | × | × | × | × |
- Citation: Clausen LN, Lundbo LF, Benfield T. Hepatitis C virus infection in the human immunodeficiency virus infected patient. World J Gastroenterol 2014; 20(34): 12132-12143
- URL: https://www.wjgnet.com/1007-9327/full/v20/i34/12132.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i34.12132